Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Bcl-2 Antikörper (pThr56)

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch Bcl-2 in IHC und ELISA. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7138865

Kurzübersicht für Bcl-2 Antikörper (pThr56) (ABIN7138865)

Target

Alle Bcl-2 (BCL2) Antikörper anzeigen
Bcl-2 (BCL2) (B-Cell CLL/lymphoma 2 (BCL2))

Reaktivität

  • 472
  • 177
  • 171
  • 37
  • 26
  • 24
  • 16
  • 9
  • 8
  • 5
  • 5
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 361
  • 162
  • 4
  • 2
  • 1
  • 1
  • 1
Kaninchen

Klonalität

  • 331
  • 200
Polyklonal

Konjugat

  • 236
  • 33
  • 32
  • 21
  • 19
  • 12
  • 11
  • 8
  • 8
  • 8
  • 8
  • 8
  • 8
  • 8
  • 8
  • 8
  • 8
  • 8
  • 8
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Bcl-2 Antikörper ist unkonjugiert

Applikation

  • 413
  • 188
  • 187
  • 147
  • 104
  • 95
  • 84
  • 80
  • 58
  • 53
  • 48
  • 24
  • 23
  • 18
  • 8
  • 8
  • 8
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), ELISA
  • Bindungsspezifität

    • 57
    • 39
    • 27
    • 23
    • 22
    • 20
    • 16
    • 16
    • 16
    • 16
    • 11
    • 11
    • 8
    • 8
    • 7
    • 7
    • 7
    • 7
    • 7
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pThr56

    Kreuzreaktivität

    Human

    Aufreinigung

    Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi

    Immunogen

    Peptide sequence around phosphorylation site of threonine 56(G-H-T(p)-P-H) derived from Human BCL-2.

    Isotyp

    IgG
  • Applikationshinweise

    IHC:1:50-1:100,

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Supplied at 1.0 mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    Bcl-2 (BCL2) (B-Cell CLL/lymphoma 2 (BCL2))

    Andere Bezeichnung

    BCL2

    Hintergrund

    Background:

     Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1).
     

    Aliases: Apoptosis regulator Bcl 2 antibody; Apoptosis regulator Bcl-2 antibody; Apoptosis regulator Bcl2 antibody; AW986256 antibody; B cell CLL/lymphoma 2 antibody; B cell leukemia/lymphoma 2 antibody; Bcl-2 antibody; Bcl2 antibody; BCL2_HUMAN antibody; C430015F12Rik antibody; D630044D05Rik antibody; D830018M01Rik antibody; Leukemia/lymphoma; B-cell; 2 antibody; Oncogene B-cell leukemia 2 antibody; PPP1R50 antibody; Protein phosphatase 1 regulatory subunit 50 antibody; Protein phosphatase 1; regulatory subunit 50 antibody

    UniProt

    P10415

    Pathways

    MAPK Signalweg, PI3K-Akt Signalweg, Apoptose, Caspase Kaskade in der Apoptose, Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Skeletal Muscle Fiber Development, Autophagie, Smooth Muscle Cell Migration, Negative Regulation of intrinsic apoptotic Signaling
Sie sind hier:
Chat with us!